IGc1Immunoglobulin C-Type |
 |
|---|
| SMART accession number: | SM00407 |
|---|---|
| Description: | |
| Interpro abstract (IPR003597): | The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106), C1-set (constant-1; IPR003597), C2-set (constant-2; IPR008424) and I-set (intermediate; IPR013098) [(PUBMED:9417933)]. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [(PUBMED:15327963), (PUBMED:11377196)]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system [(PUBMED:10698639)]. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [(PUBMED:9597133), (PUBMED:12637770)], and in various T-cell receptors. |
| Family alignment: |
There are 5297 IGc1 domains in 4937 proteins in SMART's nrdb database.
Click on the following links for more information.
- Evolution (species in which this domain is found)
-
Click on
to expand nodes. To display all proteins with a IGc1 domain in a specific node, click on it.This tree shows only several representative species. The complete taxonomic breakdown of all proteins with IGc1 domain is also avaliable.
Useful shortcuts: Expand all nodes or Collapse tree
Go to specific node: Homo sapiens, Mus musculus, Rattus norvegicus, Takifugu rubripes - Disease (disease genes where sequence variants are found in this domain)
-
SwissProt sequences and OMIM curated human diseases associated with missense mutations within the IGc1 domain.
Protein Disease UNKNOWN (SMART) OMIM:147020: Agammaglobulinemia
OMIM:601495:Ig gamma-2 chain C region (P01859) (SMART) OMIM:147110: IgG2 deficiency, selective Hereditary hemochromatosis protein (Q30201) (SMART) OMIM:235200: Hemochromatosis ; Porphyria variegata
OMIM:176200: - Metabolism (metabolic pathways involving proteins which contain this domain)
-
% proteins involved KEGG pathway ID Description 27.93 map04612 Antigen processing and presentation 26.28 map04940 Type I diabetes mellitus 26.28 map04514 Cell adhesion molecules (CAMs) 14.17 map04650 Natural killer cell mediated cytotoxicity 5.34 map04640 Hematopoietic cell lineage This information is based on mapping of SMART genomic protein database to KEGG orthologous groups. Percentage points are related to the number of proteins with IGc1 domain which could be assigned to a KEGG orthologous group, and not all proteins containing IGc1 domain. Please note that proteins can be included in multiple pathways, ie. the numbers above will not always add up to 100%.
- Structure (3D structures containing this domain)
3D Structures of IGc1 domains in PDB
PDB code Main view Title 1a1m 
Mhc class i molecule b*5301 complexed with peptide tpydinqml from gag protein of hiv2 1a1n 
Mhc class i molecule b*3501 complexed with peptide vplrpmty from the nef protein (75-82) of hiv1 1a1o 
Mhc class i molecule b*5301 complexed with peptide ls6 (kpivqydnf) from the malaria parasite p. falciparum 1a6a 
The structure of an intermediate in class ii mhc maturation: clip bound to hla-dr3 1a6z 
Hfe (human) hemochromatosis protein 1a9b 
Decamer-like conformation of a nano-peptide bound to hla- b3501 due to nonstandard positioning of the c-terminus 1a9e 
Decamer-like conformation of a nano-peptide bound to hla- b3501 due to nonstandard positioning of the c-terminus 1adq 
Crystal structure of a human igm rheumatoid factor fab in complex with its autoantigen igg fc 1agb 
Antagonist hiv-1 gag peptides induce structural changes in hla b8-hiv-1 gag peptide (ggrkkykl-3r mutation) 1agc 
Antagonist hiv-1 gag peptides induce structural changes in hla b8-hiv-1 gag peptide (ggkkkyql-7q mutation) 1agd 
Antagonist hiv-1 gag peptides induce structural changes in hla b8-hiv-1 gag peptide (ggkkkykl-index peptide) 1age 
Antagonist hiv-1 gag peptides induce structural changes in hla b8-hiv-1 gag peptide (ggkkkyrl-7r mutation) 1agf 
Antagonist hiv-1 gag peptides induce structural changes in hla b8-hiv-1 gag peptide (ggkkrykl-5r mutation) 1akj 
Complex of the human mhc class i glycoprotein hla-a2 and the t cell coreceptor cd8 1ao7 
Complex between human t-cell receptor, viral peptide (tax), and hla-a 0201 1aqd 
Hla-dr1 (dra, drb1 0101) human class ii histocompatibility protein (extracellular domain) complexed with endogenous peptide 1b0g 
Class i histocompatibility antigen (hla-a2.1)/beta 2- microglobulin/peptide p1049 complex 1b0r 
Crystal structure of hla-a*0201 complexed with a peptide with the carboxyl-terminal group substituted by a methyl group 1b3j 
Structure of the mhc class i homolog mic-a, a gammadelta t cell ligand 1bd2 
Complex between human t-cell receptor b7, viral peptide (tax) and mhc class i molecule hla-a 0201 1bii 
The crystal structure of h-2dd mhc class i in complex with the hiv-1 derived peptide p18-110 1bmg 
Crystal structure of bovine beta2-microglobulin 1bqh 
Murine cd8aa ectodomain fragment in complex with h-2kb/vsv8 1bx2 
Crystal structure of hla-dr2 (dra*0101,drb1*1501) complexed with a peptide from human myelin basic protein 1bz9 
Crystal structure of murine class i mhc h2-db complexed with a synthetic peptide p1027 1c16 
Crystal structure analysis of the gamma/delta t cell ligand t22 1cd1 
Cd1(mouse) antigen presenting molecule 1ce6 
Mhc class i h-2db complexed with a sendai virus nucleoprotein peptide 1cg9 
Complex recognition of the supertypic bw6-determinant on hla-b and-c molecules by the monoclonal antibody sfr8-b6 1cl7 
Anti hiv1 protease fab 1cqk 
Crystal structure of the ch3 domain from the mak33 antibody 1d5m 
X-ray crystal structure of hla-dr4 complexed with peptide and seb 1d5x 
X-ray crystal structure of hla-dr4 complexed with dipeptide mimetic and seb 1d5z 
X-ray crystal structure of hla-dr4 complexed with peptidomimetic and seb 1d6e 
Crystal structure of hla-dr4 complex with peptidomimetic and seb 1d9k 
Crystal structure of complex between d10 tcr and pmhc i- ak/ca 1ddh 
Mhc class i h-2dd heavy chain complexed with beta-2 microglobulin and an immunodominant peptide p18-i10 from the human immunodeficiency virus envelope glycoprotein 120 1de4 
Hemochromatosis protein hfe complexed with transferrin receptor 1dlh 
Crystal structure of the human class ii mhc protein hla-dr1 complexed with an influenza virus peptide 1dn2 
Fc fragment of human igg1 in complex with an engineered 13 residue peptide dcawhlgelvwct-nh2 1duy 
Crystal structure of hla-a*0201/octameric tax peptide complex 1duz 
Human class i histocompatibility antigen (hla-a 0201) in complex with a nonameric peptide from htlv-1 tax protein 1e27 
Nonstandard peptide binding of hla-b*5101 complexed with hiv immunodominant epitope km1(lppvvakei) 1e28 
Nonstandard peptide binding of hla-b*5101 complexed with hiv immunodominant epitope km2(taftipsi) 1e4k 
Crystal structure of soluble human igg1 fc fragment-fc-gamma receptor iii complex 1ed3 
Crystal structure of rat minor histocompatibility antigen complex rt1-aa/mtf-e. 1eey 
Crystal structure determination of hla a2 complexed to peptide gp2 with the substitution (i2l/v5l/l9v) 1eez 
Crystal structure determination of hla-a2.1 complexed to gp2 peptide variant(i2l/v5l) 1efx 
Structure of a complex between the human natural killer cell receptor kir2dl2 and a class i mhc ligand hla-cw3 1es0 
Crystal structure of the murine class ii allele i-a(g7) complexed with the glutamic acid decarboxylase (gad65) peptide 207-220 1exu 
Crystal structure of the human mhc-related fc receptor 1f3j 
Histocompatibility antigen i-ag7 1f6a 
Structure of the human ige-fc bound to its high affinity receptor fc(epsilon)ri(alpha) 1fc1 
Crystallographic refinement and atomic models of a human fc fragment and its complex with fragment b of protein a from staphylococcus aureus at 2.9-and 2.8-angstroms resolution 1fc2 
Crystallographic refinement and atomic models of a human fc fragment and its complex with fragment b of protein a from staphylococcus aureus at 2.9-and 2.8-angstroms resolution 1fcc 
Crystal structure of the c2 fragment of streptococcal protein g in complex with the fc domain of human igg 1ffn 
Crystal structure of murine class i h-2db complexed with peptide gp33(c9m) 1ffo 
Crystal structure of murine class i h-2db complexed with synthetic peptide gp33 (c9m/k1a) 1ffp 
Crystal structure of murine class i h-2db complexed with peptide gp33 (c9m/k1s) 1fg2 
Crystal structure of the lcmv peptidic epitope gp33 in complex with the murine class i mhc molecule h-2db 1fne 
Histocompatibility antigen 1fng 
Histocompatibility antigen 1fo0 
Murine alloreactive scfv tcr-peptide-mhc class i molecule complex 1fp5 
Crystal structure analysis of the human ige-fc cepsilon3- cepsilon4 fragment. 1frt 
Crystal structure of the complex of rat neonatal fc receptor with fc 1fv1 
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two hla-dr2 alleles 1fyt 
Crystal structure of a complex of a human alpha/beta-t cell receptor, influenza ha antigen peptide, and mhc class ii molecule, hla-dr1 1fzj 
Mhc class i natural mutant h-2kbm1 heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus nucleoprotein 1fzk 
Mhc class i natural mutant h-2kbm1 heavy chain complexed with beta-2 microglobulin and sendai virus nucleoprotein 1fzm 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus nucleoprotein 1fzo 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and sendai virus nucleoprotein 1g6r 
A functional hot spot for antigen recognition in a superagonist tcr/mhc complex 1g7p 
Crystal structure of mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and yeast alpha- glucosidase 1g7q 
Crystal structure of mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and muc1 vntr peptide sapdtrpa 1g84 
The solution structure of the c epsilon2 domain from ige 1gzp 
Cd1b in complex with gm2 ganglioside 1gzq 
Cd1b in complex with phophatidylinositol 1h15 
X-ray crystal structure of hla-dra1*0101/drb5*0101 complexed with a peptide from epstein barr virus dna polymerase 1h3t 
Crystal structure of the human igg1 fc-fragment,glycoform (mn2f)2 1h3u 
Crystal structure of the human igg1 fc-fragment,glycoform (m3n2f)2 1h3v 
Crystal structure of the human igg1 fc-fragment,glycoform (g2f)2,sg p212121 1h3w 
Crystal structure of the human igg1 fc-fragment,glycoform (g2f)2, sg c2221 1h3x 
Crystal structure of the human igg1 fc-fragment,glycoform (g0f)2 1h3y 
Crystal structure of a human igg1 fc-fragment,high salt condition 1hdm 
Histocompatibility antigen hla-dm 1hhg 
The antigenic identity of peptide(slash)mhc complexes: a comparison of the conformation of five peptides presented by hla-a2 1hhh 
The antigenic identity of peptide(slash)mhc complexes: a comparison of the conformation of five peptides presented by hla-a2 1hhi 
The antigenic identity of peptide(slash)mhc complexes: a comparison of the conformation of five peptides presented by hla-a2 1hhj 
The antigenic identity of peptide(slash)mhc complexes: a comparison of the conformation of five peptides presented by hla-a2 1hhk 
The antigenic identity of peptide(slash)mhc complexes: a comparison of the conformation of five peptides presented by hla-a2 1hla 
Structure of the human class i histocompatibility antigen, hla-a2 1hoc 
The three-dimensional structure of h-2db at 2.4 angstroms resolution: implications for antigen-determinant selection 1hqr 
Crystal structure of a superantigen bound to the high- affinity, zinc-dependent site on mhc class ii 1hsa 
The three-dimensional structure of hla-b27 at 2.1 angstroms resolution suggests a general mechanism for tight peptide binding to mhc 1hsb 
Different length peptides bind to hla-aw68 similarly at their ends but bulge out in the middle 1hxy 
Crystal structure of staphylococcal enterotoxin h in complex with human mhc class ii 1hyr 
Crystal structure of human mica in complex with natural killer cell receptor nkg2d 1i1a 
Crystal structure of the neonatal fc receptor complexed with a heterodimeric fc 1i1c 
Non-fcrn binding fc fragment of rat igg2a 1i1f 
Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt variant peptide i1y 1i1y 
Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt variant peptide i1y 1i3r 
Crystal structure of a mutant iek class ii mhc molecule 1i4f 
Crystal structure of hla-a*0201/mage-a4-peptide complex 1i7r 
Crystal structure of class i mhc a2 in complex with peptide p1058 1i7t 
Crystal structure of class i mhc a2 in complex with peptide p1049-5v 1i7u 
Crystal structure of class i mhc a2 in complex with peptide p1049-6v 1iak 
Histocompatibility antigen i-ak 1iao 
Class ii mhc i-ad in complex with ovalbumin peptide 323-339 1iea 
Histocompatibility antigen 1ieb 
Histocompatibility antigen 1im3 
Crystal structure of the human cytomegalovirus protein us2 bound to the mhc class i molecule hla-a2/tax 1im9 
Crystal structure of the human natural killer cell inhibitory receptor kir2dl1 bound to its mhc ligand hla-cw4 1inq 
Structure of minor histocompatibility antigen peptide, h13a, complexed to h2-db 1j8h 
Crystal structure of a complex of a human alpha/beta-t cell receptor, influenza ha antigen peptide, and mhc class ii molecule, hla-dr4 1je6 
Structure of the mhc class i homolog micb 1jf1 
Crystal structure of hla-a2*0201 in complex with a decameric altered peptide ligand from the mart-1/melan-a 1jgd 
Hla-b*2709 bound to deca-peptide s10r 1jge 
Hla-b*2705 bound to nona-peptide m9 1jht 
Crystal structure of hla-a2*0201 in complex with a nonameric altered peptide ligand (algigiltv) from the mart- 1/melan-a. 1jk8 
Crystal structure of a human insulin peptide-hla-dq8 complex 1jl4 
Crystal structure of the human cd4 n-terminal two domain fragment complexed to a class ii mhc molecule 1jnj 
Nmr solution structure of the human beta2-microglobulin 1jpf 
Crystal structure of the lcmv peptidic epitope gp276 in complex with the murine class i mhc molecule h-2db 1jpg 
Crystal structure of the lcmv peptidic epitope np396 in complex with the murine class i mhc molecule h-2db 1juf 
Structure of minor histocompatibility antigen peptide, h13b, complexed to h2-db 1jwm 
Crystal structure of the complex of the mhc class ii molecule hla-dr1(ha peptide 306-318) with the superantigen sec3 1jws 
Crystal structure of the complex of the mhc class ii molecule hla-dr1 (ha peptide 306-318) with the superantigen sec3 variant 3b1 1jwu 
Crystal structure of the complex of the mhc class ii molecule hla-dr1 (ha peptide 306-318) with the superantigen sec3 variant 3b2 1k2d 
Crystal structure of the autoimmune mhc class ii i-au complexed with myelin basic protein 1-11 at 2.2a 1k5n 
Hla-b*2709 bound to nona-peptide m9 1k8d 
Crystal structure of the non-classical mhc class ib qa-2 complexed with a self peptide 1k8i 
Crystal structure of mouse h2-dm 1kbg 
Mhc class i h-2kb presented glycopeptide rgy8-6h-gal2 1kg0 
Structure of the epstein-barr virus gp42 protein bound to the mhc class ii receptor hla-dr1 1kgc 
Immune receptor 1kj2 
Murine alloreactive scfv tcr-peptide-mhc class i molecule complex 1kj3 
Mhc class i h-2kb molecule complexed with pkb1 peptide 1kjm 
Tap-a-associated rat mhc class i molecule 1kjv 
Tap-b-associated rat mhc class i molecule 1klg 
Crystal structure of hla-dr1/tpi(23-37, thr28-->ile mutant) complexed with staphylococcal enterotoxin c3 variant 3b2 (sec3-3b2) 1klu 
Crystal structure of hla-dr1/tpi(23-37) complexed with staphylococcal enterotoxin c3 variant 3b2 (sec3-3b2) 1kpr 
The human non-classical major histocompatibility complex molecule hla-e 1kpu 
High resolution crystal structure of the mhc class i complex h-2kb/vsv8 1kpv 
High resolution crystal structure of the mhc class i complex h-2kb/sev9 1kt2 
Crystal structure of class ii mhc molecule iek bound to moth cytochrome c peptide 1ktd 
Crystal structure of class ii mhc molecule iek bound to pigeon cytochrome c peptide 1ktk 
Complex of streptococcal pyrogenic enterotoxin c (spec) with a human t cell receptor beta chain (vbeta2.1) 1ktl 
The human non-classical major histocompatibility complex molecule hla-e 1l6x 
Fc fragment of rituximab bound to a minimized version of the b-domain from protein a called z34c 1ld9 
The three-dimensional structure of an h-2ld peptide complex explains the unique interaction of ld with beta2m and peptide 1ldp 
Crystal structure of murine mhc class i h-2ld with a mixture of bound peptides 1lds 
Crystal structure of monomeric human beta-2-microglobulin 1leg 
Crystal structure of h-2kb bound to the dev8 peptide 1lek 
Crystal structure of h-2kbm3 bound to dev8 1lk2 
1.35a crystal structure of h-2kb complexed with the gnysfyal peptide 1lnu 
Crystal structure of class ii mhc molecule iab bound to ealpha3k peptide 1lo5 
Crystal structure of the d227a variant of staphylococcal enterotoxin a in complex with human mhc class ii 1lp9 
Xenoreactive complex ahiii 12.2 tcr bound to p1049/hla-a2.1 1m05 
Hla b8 in complex with an epstein barr virus determinant 1m6o 
Crystal structure of hla b*4402 in complex with hla dpa*0201 peptide 1mhc 
Model of mhc class i h2-m3 with nonapeptide from rat nd1 refined at 2.3 angstroms resolution 1mhe 
The human non-classical major histocompatibility complex molecule hla-e 1mi5 
The crystal structure of lc13 tcr in complex with hlab8-ebv peptide complex 1muj 
Crystal structure of murine class ii mhc i-ab in complex with a human clip peptide 1mwa 
2c/h-2kbm3/dev8 allogeneic complex 1n2r 
A natural selected dimorphism in hla b*44 alters self, peptide reportoire and t cell recognition. 1n3n 
Crystal structure of a mycobacterial hsp60 epitope with the murine class i mhc molecule h-2db 1n59 
Crystal structure of the murine class i major histocompatibility complex of h-2kb, b2-microglobulin, and a 9-residue immunodominant peptide epitope gp33 derived from lcmv 1n5a 
Crystal structure of the murine class i major histocompatibility complex of h-2db, b2-microglobulin, and a 9-residue immunodominant peptide epitope gp33 derived from lcmv 1nam 
Murine alloreactive scfv tcr-peptide-mhc class i molecule complex 1nan 
Mch class i h-2kb molecule complexed with pbm1 peptide 1nez 
The crystal structure of a tl/cd8aa complex at 2.1a resolution:implications for memory t cell generation, co- receptor preference and affinity 1nfd 
An alpha-beta t cell receptor (tcr) heterodimer in complex with an anti-tcr fab fragment derived from a mitogenic antibody 1ntl 
Model of mouse crry-ig determined by solution scattering, curve fitting and homology modelling 1o0v 
The crystal structure of ige fc reveals an asymmetrically bent conformation 1of2 
Crystal structure of hla-b*2709 complexed with the vasoactive intestinal peptide type 1 receptor (vipr) peptide (residues 400-408) 1oga 
A structural basis for immunodominant human t-cell receptor recognition. 1ogt 
Crystal structure of hla-b*2705 complexed with the vasoactive intestinal peptide type 1 receptor (vipr) peptide (residues 400-408) 1onq 
Crystal structure of cd1a in complex with a sulfatide 1oqo 
Complex between g0 version of an fc bound to a minimized version of protein a called mini-z 1oqx 
G-2 glycovariant of human igg fc bound to minimized version of protein a called z34c 1osz 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and an (l4v) mutant of the vesicular stomatitis virus nucleoprotein 1ow0 
Crystal structure of human fcari bound to iga1-fc 1p1z 
X-ray crystal structure of the lectin-like natural killer cell receptor ly-49c bound to its mhc class i ligand h-2kb 1p4l 
Crystal structure of nk receptor ly49c mutant with its mhc class i ligand h-2kb 1p7q 
Crystal structure of hla-a2 bound to lir-1, a host and viral mhc receptor 1pfc 
Molecular-replacement structure of guinea pig igg1 p*fc(prime) refined at 3.1 angstroms resolution 1pqz 
Murine cytomegalovirus immunomodulatory protein m144 1py4 
Beta2 microglobulin mutant h31y displays hints for amyloid formations 1pyw 
Human class ii mhc protein hla-dr1 bound to a designed peptide related to influenza virus hemagglutinin, fvkqna(maa)al, in complex with staphylococcal enterotoxin c3 variant 3b2 (sec3-3b2) 1q94 
Structures of hla-a*1101 in complex with immunodominant nonamer and decamer hiv-1 epitopes clearly reveal the presence of a middle anchor residue 1qew 
Human class i histocompatibility antigen (hla-a 0201) complex with a nonameric peptide from melanoma-associated antigen 3 (residues 271-279) 1qlf 
Mhc class i h-2db complexed with glycopeptide k3g 1qo3 
Complex between nk cell receptor ly49a and its mhc class i ligand h-2dd 1qqd 
Crystal structure of hla-cw4, a ligand for the kir2d natural killer cell inhibitory receptor 1qr1 
Poor binding of a her-2/neu epitope (gp2) to hla-a2.1 is due to a lack of interactions in the center of the peptide 1qrn 
Crystal structure of human a6 tcr complexed with hla-a2 bound to altered htlv-1 tax peptide p6a 1qse 
Structure of human a6-tcr bound to hla-a2 complexed with altered htlv-1 tax peptide v7r 1qsf 
Structure of a6-tcr bound to hla-a2 complexed with altered htlv-1 tax peptide y8a 1qvo 
Structures of hla-a*1101 in complex with immunodominant nonamer and decamer hiv-1 epitopes clearly reveal the presence of a middle anchor residue 1r3h 
Crystal structure of t10 1r5i 
Crystal structure of the mam-mhc complex 1r5v 
Evidence that structural rearrangements and/or flexibility during tcr binding can contribute to t-cell activation 1r5w 
Evidence that structural rearrangements and/or flexibility during tcr binding can contribute to t-cell activation 1rjy 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and herpes simplex virus glycoprotein b peptide 1rjz 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and herpies simplex virus mutant glycoprotein b peptide 1rk0 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and herpes simplex virus glycoprotein b peptide 1rk1 
Mhc class i natural h-2kb heavy chain complexed with beta-2 microglobulin and herpes simplex virus mutant glycoprotein b peptide 1s7q 
Crystal structures of the murine class i major histocompatibility complex h-2kb in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7r 
Crystal structures of the murine class i major histocompatibility complex h-2kb in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7s 
Crystal structures of the murine class i major histocompatibility complex h-2kb in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7t 
Crystal structures of the murine class i major histocompatibility complex h-2kb in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7u 
Crystal structures of the murine class i major histocompatibility complex h-2db in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7v 
Crystal structures of the murine class i major histocompatibility complex h-2db in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7w 
Crystal structures of the murine class i major histocompatibility complex h-2db in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s7x 
Crystal structures of the murine class i major histocompatibility complex h-2db in complex with lcmv- derived gp33 index peptide and three of its escape variants 1s8d 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-3a 1s9v 
Crystal structure of hla-dq2 complexed with deamidated gliadin peptide 1s9w 
Crystal structure analysis of ny-eso-1 epitope, sllmwitqc, in complex with hla-a2 1s9x 
Crystal structure analysis of ny-eso-1 epitope analogue, sllmwitqa, in complex with hla-a2 1s9y 
Crystal structure analysis of ny-eso-1 epitope analogue, sllmwitqs, in complex with hla-a2 1seb 
Complex of the human mhc class ii glycoprotein hla-dr1 and the bacterial superantigen seb 1sje 
Hla-dr1 complexed with a 16 residue hiv capsid peptide bound in a hairpin conformation 1sjh 
Hla-dr1 complexed with a 13 residue hiv capsid peptide 1sys 
Crystal structure of hla, b*4403, and peptide eeptvikky 1syv 
Hla-b*4405 complexed to the dominant self ligand eefgraygf 1t0m 
Conformational switch in polymorphic h-2k molecules containing an hsv peptide 1t0n 
Conformational switch in polymorphic h-2k molecules containing an hsv peptide 1t1w 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-3f6i8v 1t1x 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-4l 1t1y 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-5v 1t1z 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-6a 1t20 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9-6i 1t21 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9, monoclinic crystal 1t22 
Structural basis for degenerate recognition of hiv peptide variants by cytotoxic lymphocyte, variant sl9, orthorhombic crystal 1t5w 
Hla-dr1 in complex with a synthetic peptide (aaysdqatplllspr) 1t5x 
Hla-dr1 in complex with a synthetic peptide (aaysdqatplllspr) and the superantigen sec3-3b2 1t7v 
Zn-alpha-2-glycoprotein; baculo-zag peg 200 1t7w 
Zn-alpha-2-glycoprotein; cho-zag peg 400 1t7x 
Zn-alpha-2-glycoprotein; refolded cho-zag peg 400 1t7y 
Zn-alpha-2-glycoprotein; baculo-zag peg 200, no glycerol 1t7z 
Zn-alpha-2-glycoprotein; baculo-zag no peg, no glycerol 1t80 
Zn-alpha-2-glycoprotein; cho-zag peg 200 1t83 
Crystal structure of a human type iii fc gamma receptor in complex with an fc fragment of igg1 (orthorhombic) 1t89 
Crystal structure of a human type iii fc gamma receptor in complex with an fc fragment of igg1 (hexagonal) 1tmc 
The three-dimensional structure of a class i major histocompatibility complex molecule missing the alpha3 domain of the heavy chain 1tvb 
Crystal structure of melanoma antigen gp100(209-217) bound to human class i mhc hla-a2 1tvh 
Crystal structure of modified melanoma antigen gp100(209- t2m) bound to human class i mhc hla-a2 1u3h 
Crystal structure of mouse tcr 172.10 complexed with mhc class ii i-au molecule at 2.4 a 1u58 
Crystal structure of the murine cytomegalovirus mhc-i homolog m144 1uqs 
The crystal structure of human cd1b with a bound bacterial glycolipid 1uvq 
Crystal structure of hla-dq0602 in complex with a hypocretin peptide 1uxs 
Crystal structure of hla-b*2705 complexed with the latent membrane protein 2 peptide (lmp2)of epstein-barr virus 1uxw 
Crystal structure of hla-b*2709 complexed with the latent membrane protein 2 peptide (lmp2) of epstein-barr virus 1vac 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and chicken ovalbumin 1vad 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and yeast alpha-glucosidase 1vgk 
The crystal structure of class i major histocompatibility complex, h-2kd at 2.0 a resolution 1w0v 
Crystal structure of hla-b*2705 complexed with the self-peptide tis from egf-response factor 1 1w0w 
Crystal structure of hla-b*2709 complexed with the self-peptide tis from egf-response factor 1 1w72 
Crystal structure of hla-a1:mage-a1 in complex with fab- hyb3 1wbx 
Crystal structures of murine mhc class i h-2 db and kb molecules in complex with ctl epitopes from influenza a virus: implications for tcr repertoire selection and immunodominance 1wby 
Crystal structures of murine mhc class i h-2 db and kb molecules in complex with ctl epitopes from influenza a virus: implications for tcr repertoire selection and immunodominance 1wbz 
Crystal structures of murine mhc class i h-2 db and kb molecules in complex with ctl epitopes from influenza a virus: implications for tcr repertoire selection and immunodominance 1x7q 
Crystal structure of hla-a*1101 with sars nucleocapsid peptide 1xh3 
Conformational restraints and flexibility of 14-meric peptides in complex with hla-b*3501 1xr8 
Crystal structures of hla-b*1501 in complex with peptides from human ubch6 and epstein-barr virus ebna-3 1xr9 
Crystal structures of hla-b*1501 in complex with peptides from human ubch6 and epstein-barr virus ebna-3 1xz0 
Crystal structure of cd1a in complex with a synthetic mycobactin lipopeptide 1ydp 
1.9a crystal structure of hla-g 1ymm 
Tcr/hla-dr2b/mbp-peptide complex 1yn6 
Crystal structure of a mouse mhc class i protein, h2-db, in complex with a peptide from the influenza a acid polymerase 1yn7 
Crystal structure of a mouse mhc class i protein, h2-db, in complex with a mutated peptide (r7a) of the influenza a acid polymerase 1ypz 
Immune receptor 1z5l 
Structure of a highly potent short-chain galactosyl ceramide agonist bound to cd1d 1zag 
Human zinc-alpha-2-glycoprotein 1zgl 
Crystal structure of 3a6 tcr bound to mbp/hla-dr2a 1zhb 
Crystal structure of the murine class i major histocompatibility complex of h-2db, b2-microglobulin, and a 9-residue peptide derived from rat dopamine beta- monooxigenase 1zhk 
Crystal structure of hla-b*3501 presenting 13-mer ebv antigen lpeplpqgqltay 1zhl 
Crystal structure of hla-b*3508 presenting 13-mer ebv antigen lpeplpqgqltay 1zhn 
Crystal structure of mouse cd1d bound to the self ligand phosphatidylcholine 1zs8 
Crystal structure of the murine mhc class ib molecule m10.5 1zsd 
Crystal structure of hla-b*3501 presenting an 11-mer ebv antigen eplpqgqltay 1zt1 
Crystal structure of class i mhc h-2kk in complex with an octapeptide 1zt4 
The crystal structure of human cd1d with and without alpha- galactosylceramide 1zt7 
Crystal structure of class i mhc h-2kk in complex with a nonapeptide 1zvs 
Crystal structure of the first class mhc mamu and tat-tl8 complex 2a83 
Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420) 2ak4 
Crystal structure of sb27 tcr in complex with hla-b*3508- 13mer peptide 2akr 
Structural basis of sulfatide presentation by mouse cd1d 2aty 
Complement receptor chimaeric conjugate cr2-ig 2av1 
Crystal structure of htlv-1 tax peptide bound to human class i mhc hla-a2 with the e63q and k66a mutations in the heavy chain. 2av7 
Crystal structure of htlv-1 tax peptide bound to human class i mhc hla-a2 with the k66a mutation in the heavy chain. 2axf 
The immunogenicity of a viral cytotoxic t cell epitope is controlled by its mhc-bound conformation 2axg 
The immunogenicity of a viral cytotoxic t cell epitope is controlled by its mhc-bound conformation 2axh 
Crystal structures of t cell receptor beta chains related to rheumatoid arthritis 2axj 
Crystal structures of t cell receptor beta chains related to rheumatoid arthritis 2bc4 
Crystal structure of hla-dm 2bck 
Crystal structure of hla-a*2402 complexed with a telomerase peptide 2bnq 
Structural and kinetic basis for heightened immunogenicity of t cell vaccines 2bnr 
Structural and kinetic basis for heightened immunogenicity of t cell vaccines 2bnu 
Structural and kinetic basis for heightened immunogenicity of t cell vaccines 2bsr 
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 2bss 
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 2bst 
Crystal structures and kir3dl1 recognition of three immunodominant viral peptides complexed to hla-b2705 2bvo 
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression 2bvp 
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression 2bvq 
Structures of three hiv-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression 2c7u 
Conflicting selective forces affect cd8 t-cell receptor contact sites in an hla-a2 immunodominant hiv epitope. 2cde 
Structure and binding kinetics of three different human cd1d-alpha-galactosylceramide specific t cell receptors - inkt-tcr 2cdf 
Structure and binding kinetics of three different human cd1d-alpha-galactosylceramide-specific t cell receptors (tcr 5e) 2cdg 
Structure and binding kinetics of three different human cd1d-alpha-galactosylceramide-specific t cell receptors (tcr 5b) 2cii 
The crystal structure of h-2db complexed with a partial peptide epitope suggests an mhc class i assembly- intermediate 2cik 
Insights into crossreactivity in human allorecognition: the structure of hla-b35011 presenting an epitope derived from cytochrome p450. 2ckb 
Structure of the 2c/kb/dev8 complex 2clr 
Three dimensional structure of a peptide extending out one end of a class i mhc binding site 2clv 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and pbm8 peptide 2clz 
Mhc class i natural mutant h-2kbm8 heavy chain complexed with beta-2 microglobulin and pbm1 peptide 2d31 
Crystal structure of disulfide-linked hla-g dimer 2d4d 
The crystal structure of human beta2-microglobulin, l39w w60f w95f mutant 2d4f 
The crystal structure of human beta2-microglobulin 2dtq 
Crystal structure of the fucosylated fc fragment from human immunoglobulin g1 2dts 
Crystal structure of the defucosylated fc fragment from human immunoglobulin g1 2dyp 
Crystal structure of lilrb2(lir2/ilt4/cd85d) complexed with hla-g 2esv 
Structure of the hla-e-vmaprtlil/kk50.4 tcr complex 2eyr 
A structural basis for selection and cross-species reactivity of the semi-invariant nkt cell receptor in cd1d/glycolipid recognition 2eys 
A structural basis for selection and cross-species reactivity of the semi-invariant nkt cell receptor in cd1d/glycolipid recognition 2eyt 
A structural basis for selection and cross-species reactivity of the semi-invariant nkt cell receptor in cd1d/glycolipid recognition 2f53 
Directed evolution of human t-cell receptor cdr2 residues by phage display dramatically enhances affinity for cognate peptide-mhc without apparent cross-reactivity 2f54 
Directed evolution of human t cell receptor cdr2 residues by phage display dramatically enhances affinity for cognate peptide-mhc without increasing apparent cross- reactivity 2f74 
Murine mhc class i h-2db in complex with human b2- microglobulin and lcmv-derived immunodminant peptide gp33 2f8o 
A native to amyloidogenic transition regulated by a backbone trigger 2fik 
Structure of a microbial glycosphingolipid bound to mouse cd1d 2fo4 
Enhanced mhc class i binding and immune responses through anchor modification of the non-canonical tumor associated muc1-8 peptide 2fse 
Crystallographic structure of a rheumatoid arthritis mhc susceptibility allele, hla-dr1 (drb1*0101), complexed with the immunodominant determinant of human type ii collagen 2fwo 
Mhc class i h-2kd heavy chain in complex with beta- 2microglobulin and peptide derived from influenza nucleoprotein 2fyy 
The role of t cell receptor alpha genes in directing human mhc restriction 2fz3 
The role of t cell receptor alpha genes in directing human mhc restriction 2g9h 
Crystal structure of staphylococcal enterotoxin i (sei) in complex with a human mhc class ii molecule 2gaz 
Mycobacterial lipoglycan presentation by cd1d 2git 
Human class i mhc hla-a2 in complex with the modified htlv- tax (y5k-4-[3-indolyl]-butyric acid) peptide 2gj6 
The complex between tcr a6 and human class i mhc hla-a2 with the modified htlv-1 tax (y5k-4-[3-indolyl]-butyric acid) peptide 2gj7 
Crystal structure of a ge-gi/fc complex 2gt9 
Human class i mhc hla-a2 in complex with the decameric melan-a/mart-1(26-35) peptide 2gtw 
Human class i mhc hla-a2 in complex with the nonameric melan-a/mart-1(27-35) peptide having a27l substitution 2gtz 
Human class i mhc hla-a2 in complex with the nonameric melan-a/mart-1(27-35) peptide having a28l substitution 2guo 
Human class i mhc hla-a2 in complex with the native nonameric melan-a/mart-1(27-35) peptide 2h26 
Human cd1b in complex with endogenous phosphatidylcholine and spacer 2h32 
Crystal structure of the pre-b cell receptor 2h3n 
Crystal structure of a surrogate light chain (lambda5 and vpreb) homodimer 2h6p 
Crystal structure of hla-b*3501 presenting the human cytochrome p450 derived peptide, kpivvlhgy 2hjk 
Crystal structure of hla-b5703 and hiv-1 peptide 2hjl 
Crystal structure of hla-b5703 and hiv-1 peptide 2hla 
Specificity pockets for the side chains of peptide antigens in hla-aw68 2hn7 
Hla-a*1101 in complex with hbv peptide homologue 2iad 
Class ii mhc i-ad in complex with an influenza hemagglutinin peptide 126-138 2ial 
Structural basis for recognition of mutant self by a tumor- specific, mhc class ii-restricted tcr 2iam 
Structural basis for recognition of mutant self by a tumor- specific, mhc class ii-restricted tcr 2ian 
Structural basis for recognition of mutant self by a tumor- specific, mhc class ii-restricted tcr 2icw 
Crystal structure of a complete ternary complex between tcr, superantigen, and peptide-mhc class ii molecule 2ipk 
Crystal structure of the mhc class ii molecule hla-dr1 in complex with the fluorogenic peptide, acpkxvkqntlklat (x=3- [5-(dimethylamino)-1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl]- l-alanine) and the superantigen, sec3 variant 3b2 2iwg 
Complex between the pryspry domain of trim21 and igg fc 2j6e 
Crystal structure of an autoimmune complex between a human igm rheumatoid factor and igg1 fc reveals a novel fc epitope and evidence for affinity maturation 2j8u 
Large cdr3a loop alteration as a function of mhc mutation. 2jcc 
Ah3 recognition of mutant hla-a2 w167a 2mha 
Crystal structure of the major histocompatibility complex class i h-2kb molecule containing a single viral peptide: implications for peptide binding and t-cell receptor recognition 2nna 
Structure of the mhc class ii molecule hla-dq8 bound with a deamidated gluten peptide 2nts 
Crystal structure of sek-hvb5.1 2nw3 
Crystal structure of hla-b*3508 presenting ebv peptide eplpqgqltay at 1.7a 2nx5 
Crystal structure of els4 tcr bound to hla-b*3508 presenting ebv peptide eplpqgqltay at 1.7a 2oje 
Mycoplasma arthritidis-derived mitogen complexed with class ii mhc molecule hla-dr1/ha complex in the presence of edta 2ol3 
Crystal structure of bm3.3 scfv tcr in complex with pbm8-h- 2kbm8 mhc class i molecule 2p24 
I-au/mbp125-135 2p5e 
Crystal structures of high affinity human t-cell receptors bound to pmhc reveal native diagonal binding geometry 2p5w 
Crystal structures of high affinity human t-cell receptors bound to pmhc reveal native diagonal binding geometry 2po6 
Crystal structure of cd1d-lipid-antigen complexed with beta- 2-microglobulin, nkt15 alpha-chain and nkt15 beta-chain 2pxy 
Crystal structures of immune receptor complexes 2pye 
Crystal structures of high affinity human t-cell receptors bound to pmhc revealnative diagonal binding geometry tcr clone c5c1 complexed with mhc 2pyf 
Crystal structures of high affinity human t-cell receptors bound to pmhc revealnative diagonal binding geometry unbound tcr clone 5-1 2q6w 
The structure of hla-dra, drb3*0101 (dr52a) with bound platelet integrin peptide associated with fetal and neonatal alloimmune thrombocytopenia 2q7y 
Structure of the endogenous inkt cell ligand igb3 bound to mcd1d 2qej 
Crystal structure of a staphylococcus aureus protein (ssl7) in complex with fc of human iga1 2ql1 
Structural characterization of a mutated, adcc-enhanced human fc fragment 2qri 
Crystal structure of a single chain trimer composed of the mhc i heavy chain h-2kb wt, beta-2microglobulin, and ovalbumin-derived peptide. 2qrs 
Crystal structure of a single chain trimer composed of the mhc i heavy chain h-2kb y84a, beta-2microglobulin, and ovalbumin-derived peptide. 2qrt 
Crystal structure of a disulfide trapped single chain trimer composed of the mhc i heavy chain h-2kb y84c, beta- 2microglobulin, and ovalbumin-derived peptide. 2rcj 
Solution structure of human immunoglobulin m 2rfx 
Crystal structure of hla-b*5701, presenting the self peptide, lsspvtksf 2rgs 
Fc-fragment of monoclonal antibody igg2b from mus musculus 2seb 
X-ray crystal structure of hla-dr4 complexed with a peptide from human collagen ii 2uwe 
Large cdr3a loop alteration as a function of mhc mutation 2v2w 
T cell cross-reactivity and conformational changes during tcr engagement 2v2x 
T cell cross-reactivity and conformational changes during tcr engagement. 2vaa 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus nucleoprotein 2vab 
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and sendai virus nucleoprotein 2vb5 
Solution structure of w60g mutant of human beta2- microglobulin 2ve6 
Crystal structure of a murine mhc class i h2-db molecule in complex with a photocleavable peptide 2vlj 
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain 2vlk 
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain 2vll 
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain 2vlm 
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain 2vlr 
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain 2vol 
Murine trim21 in complex with murine igg fc 2vuo 
Crystal structure of the rabbit igg fc fragment 2w59 
Structure of an avian igy-fc 3-4 fragment 2wah 
Crystal structure of an igg1 fc glycoform (man9glcnac2) 2wbj 
Tcr complex 2wng 
Complete extracellular structure of human signal regulatory protein (sirp) alpha 2yxf 
The high resolution crystal structure of beta2- microglobulin under physiological conditions 2z31 
Crystal structure of immune receptor complex 2z9t 
Crystal structure of the human beta-2 microglobulin mutant w60g 2zok 
Crystal structure of h-2db in complex with jhmv epitope s510 2zol 
Crystal structure of h-2db in complex with the w513s variant of jhmv epitope s510 2zsv 
Crystal structure of h-2kb in complex with jhmv epitope s598 2zsw 
Crystal structure of h-2kb in complex with the q600y variant of jhmv epitope s598 3b3i 
Citrullination-dependent differential presentation of a self-peptide by hla-b27 subtypes 3b6s 
Crystal structure of hla-b*2705 complexed with the citrullinated vasoactive intestinal peptide type 1 receptor (vipr) peptide (residues 400-408) 3bev 
11mer structure of an mhc class i molecule from b21 chickens illustrate promiscuous peptide binding 3bew 
10mer crystal structure of chicken mhc class i haplotype b21 3bgm 
Crystal structure of pkd2 phosphopeptide bound to human class i mhc hla-a2 3bh8 
Crystal structure of rqa_m phosphopeptide bound to human class i mhc hla-a2 3bh9 
Crystal structure of rty phosphopeptide bound to human class i mhc hla-a2 3bhb 
Crystal structure of kmd phosphopeptide bound to human class i mhc hla-a2 3bo8 
The high resolution crystal structure of hla-a1 complexed with the mage-a1 peptide 3bp4 
The high resolution crystal structure of hla-b*2705 in complex with a cathepsin a signal sequence peptide pcata 3bp7 
The high resolution crystal structure of hla-b*2709 in complex with a cathepsin a signal sequence peptide, pcata 3buy 
Mhc-i in complex with peptide 3bvn 
High resolution crystal structure of hla-b*1402 in complex with the latent membrane protein 2 peptide (lmp2) of epstein-barr virus 3bw9 
Crystal structure of hla b*3508 in complex with a hcmv 12- mer peptide from the pp65 protein 3bwa 
Crystal structure of hla b*3508 in complex with a hcmv 8- mer peptide from the pp65 protein 3bxn 
The high resolution crystal structure of hla-b*1402 complexed with a cathepsin a signal sequence peptide, pcata 3bze 
The human non-classical major histocompatibility complex molecule hla-e 3bzf 
The human non-classical major histocompatibility complex molecule hla-e 3c2s 
Structural characterization of a human fc fragment engineered for lack of effector functions 3c5j 
Crystal structure of hla dr52c 3c5z 
Crystal structure of mouse mhc class ii i-ab/3k peptide complexed with mouse tcr b3k506 3c60 
Crystal structure of mouse mhc class ii i-ab/3k peptide complexed with mouse tcr yae62 3c6l 
Crystal structure of mouse mhc class ii i-ab/3k peptide complexed with mouse tcr 2w20 3c8k 
The crystal structure of ly49c bound to h-2kb 3c9n 
Crystal structure of a sars corona virus derived peptide bound to the human major histocompatibility complex class i molecule hla-b*1501 3cc5 
H-2db complex with human gp100 3cch 
H-2db complex with murine gp100 3cdg 
Human cd94/nkg2a in complex with hla-e 3ch1 
Crystal structure of h-2db in complex with chimeric gp100 3cii 
Structure of nkg2a/cd94 bound to hla-e 3ciq 
A regulatable switch mediates self-association in an immunoglobulin fold 3cpl 
Crystal structure of h-2db in complex with a variant m6a of the np366 peptide from influenza a virus 3cup 
Crystal structure of the mhc class ii molecule i-ag7 in complex with the peptide gad221-235 3cvh 
How tcr-like antibody recognizes mhc-bound peptide 3czf 
Crystal structure of hla-b*2709 complexed with the glucagon receptor (gr) peptide (residues 412-420) 3d18 
Crystal structure of hla-b*2709 complexed with a variant of the latent membrane protein 2 peptide (lmp2(l)) of epstein- barr virus 3d25 
Crystal structure of ha-1 minor histocompatibility antigen bound to human class i mhc hla-a2 3d2u 
Structure of ul18, a peptide-binding viral mhc mimic, bound to a host inhibitory receptor 3d39 
The complex between tcr a6 and human class i mhc hla-a2 with the modified htlv-1 tax (y5(4-fluorophenylalanine)) peptide 3d3v 
The complex between tcr a6 and human class i mhc hla-a2 with the modified htlv-1 tax (y5(3,4-difluorophenylalanine)) peptide 3d6g 
Fc fragment of igg1 (herceptin) with protein-a mimetic peptide dendrimer ligand. 3dbx 
Structure of chicken cd1-2 with bound fatty acid 3dhj 
Beta 2 microglobulin mutant w60c 3dhm 
Beta 2 microglobulin mutant d59p 3dmm 
Crystal structure of the cd8 alpha beta/h-2dd complex 3dnk 
Enzyme deglycosylated human igg1 fc fragment 3do3 
Human 1gg1 fc fragment, 2.5 angstrom structure 3dtx 
Crystal structure of hla-b*2705 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (vipr) peptide (residues 400-408) 3dx6 
Crystal structure of b*4402 presenting a 10mer ebv epitope 3dx7 
Crystal structure of hla-b*4403 presenting 10mer ebv antigen 3dx8 
Crystal structure of b*4405 presenting a 10mer ebv epitope 3dx9 
Crystal structure of the dm1 tcr at 2.75a 3dxa 
Crystal structure of the dm1 tcr in complex with hla-b*4405 and decamer ebv antigen 3e6f 
Mhc class i h-2dd heavy chain complexed with beta-2 microglobulin and a variant peptide, pa9, from the human immunodeficiency virus (bal) envelope glycoprotein 120 3e6h 
Mhc class i h-2dd heavy chain complexed with beta-2 microglobulin and a variant peptide, pi10, from the human immunodeficiency virus (bal) envelope glycoprotein 120 3ecb 
Crystal structure of mouse h-2dd in complex with peptide p18-i10 derived from human immunodeficiency virus envelope glycoprotein 120 3ekc 
Structure of w60v beta-2 microglobulin mutant 3es6 
Crystal structure of the novel complex formed between zinc 2-glycoprotein (zag) and prolactin inducible protein (pip) from human seminal plasma 3ffc 
Crystal structure of cf34 tcr in complex with hla-b8/flr 3fjt 
Crystal structure of a human fc fragment engineered for extended serum half-life 3fqn 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fqr 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fqt 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fqu 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fqw 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fqx 
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes 3fru 
Neonatal fc receptor, ph 6.5 3ft2 
Crystal structure of a citrulline peptide variant of the minor histocompatibility peptide ha-1 in complex with hla- a2 3ft3 
Crystal structure of the minor histocompatibility peptide ha-1his in complex with hla-a2 3ft4 
Crystal structure of the minor histocompatibility peptide ha-1arg in complex with hla-a2 3giv 
Antigen processing influences hiv-specific cytotoxic t lymphocyte immunodominance 3gjf 
Rational development of high-affinity t-cell receptor-like antibodies 3gml 
Structure of mouse cd1d in complex with c6ph 3gmm 
Structure of mouse cd1d in complex with c8ph 3gmn 
Structure of mouse cd1d in complex with c10ph 3gmo 
Structure of mouse cd1d in complex with c8phf 3gmp 
Structure of mouse cd1d in complex with pbs-25 3gmq 
Structure of mouse cd1d expressed in sf9 cells, no ligand added 3gmr 
Structure of mouse cd1d in complex with c8ph, different space group 3gsn 
Crystal structure of the public ra14 tcr in complex with the hcmv dominant nlv/hla-a2 epitope 3gso 
Crystal structure of the binary complex between hla-a2 and hcmv nlv peptide 3gsq 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-m5s peptide variant 3gsr 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-m5v peptide variant 3gsu 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-m5t peptide variant 3gsv 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-m5q peptide variant 3gsw 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-t8a peptide variant 3gsx 
Crystal structure of the binary complex between hla-a2 and hcmv nlv-t8v peptide variant 3h9y 
Crystal structure of the ige-fc3-4 domains 3h9z 
Crystal structure of the ige-fc3-4 domains 3ha0 
Crystal structure of the ige-fc3-4 domains 3hae 
Rational development of high-affinity t-cell receptor-like antibodies 3hcv 
Crystal structure of hla-b*2709 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (vipr) peptide (residues 400-408) 3he6 
Crystal structure of mouse cd1d-alpha-galactosylceramide with mouse valpha14-vbeta8.2 nkt tcr 3he7 
Crystal structure of mouse cd1d-alpha-galactosylceramide with mouse valpha14-vbeta7 nkt tcr 3hg1 
Germline-governed recognition of a cancer epitope by an immunodominant human t cell receptor 3hkf 
Murine unglycosylated igg fc fragment 3hla 
Human class i histocompatibility antigen a2.1 3huj 
Crystal structure of human cd1d-alpha-galactosylceramide in complex with semi-invariant nkt cell receptor - Links (links to other resources describing this domain)
-
PFAM ig INTERPRO IPR003597 PROSITE IG_MHC